German medical device company Biotronik launches its Ilesto line of implantable cardioverter-defibrillators and cardiac resynchronization therapy defibrillators, beginning with its Ilesto DX platform.

Biotronik is beginning the launch of its newly approved Ilesto line of thinner, smaller cardiac implants with the remotely monitored Ilesto DX platform, the company announced today.

The Ilesto line of implants is 15% smaller and requires 29% fewer components than its predecessors, Biotronik said, and the DX devices allow physicians to monitor atrial information and possibly diagnose previously undetected instance of atrial fibrillation.